NCT07463833Recruiting
Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation Oncology
Development and Assessment of Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation Oncology
Source: ClinicalTrials.gov · Last updated 23 Jun 2026
Brief summary (registry, in English)
This prospective study will test artificial intelligence (AI) and machine learning (ML) decision support tools. This tool is designed to help doctors, physicists and other staff during pre-treatment peer review, a step where treatment plans are checked before a patient begins care. The system highlights summaries showing how different providers may vary in their treatment planning (provider-variability summaries) and points out the best signals or warning signs to look for (optimal cues). By drawing attention to these patterns and cues, the tool aims to help reviewers spot possible treatment-planning mistakes earlier, reduce the chance of errors, and improve overall patient safety.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 207 (estimated)
- First submitted
- 5 Mar 2026
- Start date
- 22 Jun 2026
- Primary completion date
- Jul 2027
- Lead sponsor
- UNC Lineberger Comprehensive Cancer Center
- Diseases
- Prostate cancer
- NCT number
- NCT07463833
What you commit to
- Study type: Interventional
- Planned participants: 207
- From 22 Jun 2026 to the primary completion date, Jul 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Has dementia, altered mental status, or any psychiatric or co-morbid condition prohibiting the understanding or rendering of informed consent
Other
- Providers only
- Providers unwilling/unable to comply with study procedures; sites unable to implement the workflow or provide required outcomes.
- Patients and Providers
Who the study is looking for
- Providers only
- ≥18 years
- Peer-review attendees at participating clinics
- Patients only
- ≥18 years
- All patients with prostate cancer radiation therapy cases treated at participating sites (no intervention delivered to patients)
Criteria the registry did not label
- In order to participate in this study a subject must meet all of the eligibility criteria outlined below.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of North Carolina at Chapel Hill, Department of Radiation Oncology Coordinator of this site? Confirm its status | Chapel Hill | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.